775 related articles for article (PubMed ID: 19191184)
1. Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis.
Chen TA; Tsao YC; Chen A; Lo GH; Lin CK; Yu HC; Cheng LC; Hsu PI; Tsai WL
Scand J Gastroenterol; 2009; 44(5):619-25. PubMed ID: 19191184
[TBL] [Abstract][Full Text] [Related]
2. Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis.
Fernández J; Navasa M; Garcia-Pagan JC; G-Abraldes J; Jiménez W; Bosch J; Arroyo V
J Hepatol; 2004 Sep; 41(3):384-90. PubMed ID: 15336440
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality.
Navasa M; Follo A; Filella X; Jiménez W; Francitorra A; Planas R; Rimola A; Arroyo V; Rodés J
Hepatology; 1998 May; 27(5):1227-32. PubMed ID: 9581675
[TBL] [Abstract][Full Text] [Related]
4. Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: a randomized prospective study.
Choi CH; Ahn SH; Kim DY; Lee SK; Park JY; Chon CY; Moon YM; Han KH
J Gastroenterol Hepatol; 2005 Aug; 20(8):1215-22. PubMed ID: 16048569
[TBL] [Abstract][Full Text] [Related]
5. Sequential changes in plasma cytokine and endotoxin levels in cirrhotic patients with bacterial infection.
Wang SS; Lee FY; Chan CC; Lu RH; Chao Y; Lin HC; Wu SL; Tsai YT; Lee SD
Clin Sci (Lond); 2000 Apr; 98(4):419-25. PubMed ID: 10731475
[TBL] [Abstract][Full Text] [Related]
6. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
Bajaj JS; Zadvornova Y; Heuman DM; Hafeezullah M; Hoffmann RG; Sanyal AJ; Saeian K
Am J Gastroenterol; 2009 May; 104(5):1130-4. PubMed ID: 19337238
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte subsets and cytokines in ascitic fluid of decompensated cirrhotic patients with and without spontaneous ascites infection.
Kiyici M; Nak SG; Budak F; Gurel S; Oral B; Dolar E; Gulten M
J Gastroenterol Hepatol; 2006 Jun; 21(6):963-9. PubMed ID: 16724979
[TBL] [Abstract][Full Text] [Related]
9. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.
Sort P; Navasa M; Arroyo V; Aldeguer X; Planas R; Ruiz-del-Arbol L; Castells L; Vargas V; Soriano G; Guevara M; Ginès P; Rodés J
N Engl J Med; 1999 Aug; 341(6):403-9. PubMed ID: 10432325
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis.
Genesca J; Gonzalez A; Segura R; Catalan R; Marti R; Varela E; Cadelina G; Martinez M; Lopez-Talavera JC; Esteban R; Groszmann RJ; Guardia J
Am J Gastroenterol; 1999 Jan; 94(1):169-77. PubMed ID: 9934750
[TBL] [Abstract][Full Text] [Related]
11. Pilot study: Gelafundin (polygeline) 4% plus antibiotics in the treatment of high-risk cirrhotic patients with spontaneous bacterial peritonitis.
Cartier M; Terg R; Lucero R; Muñoz A; Romero G; Levi D; Miguez C; Abecasis R
Aliment Pharmacol Ther; 2010 Jul; 32(1):43-8. PubMed ID: 20345510
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of different therapeutic approaches for spontaneous bacterial peritonitis.
Abd Elaal MM; Zaghloul SG; Bakr HG; Ashour MA; Abdel-Aziz-El-Hady H; Khalifa NA; Amr GE
Arab J Gastroenterol; 2012 Jun; 13(2):65-70. PubMed ID: 22980594
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous bacterial peritonitis results in oxidative and nitrosative stress in ascitic fluid.
Natarajan SK; Mukhopadhya A; Ramachandran A; Amalanathan S; Kurian G; Balasubramanian KA
J Gastroenterol Hepatol; 2007 Feb; 22(2):177-81. PubMed ID: 17295868
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 6 concentration in ascitic fluid of cirrhotic patients: relationship with previous episodes of spontaneous bacterial peritonitis.
Souza MH; Cunha FQ; Martinelli AL
J Gastroenterol; 2003; 38(2):149-52. PubMed ID: 12640528
[TBL] [Abstract][Full Text] [Related]
15. Long-lasting NO overproduction in cirrhotic patients with spontaneous bacterial peritonitis.
Bories PN; Campillo B; Azaou L; Scherman E
Hepatology; 1997 Jun; 25(6):1328-33. PubMed ID: 9185747
[TBL] [Abstract][Full Text] [Related]
16. Assessing the risk of decompensation by ascites and spontaneous bacterial peritonitis in cirrhosis.
Dănulescu RM; Stanciu C; Trifan A
Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):320-6. PubMed ID: 25076694
[TBL] [Abstract][Full Text] [Related]
17. [Effect of anti-endotoxin therapy on vaso-active substances in decompensated liver cirrhosis].
Zhuang L; Ma Z; Liu T
Zhonghua Gan Zang Bing Za Zhi; 2000 Apr; 8(2):94-5. PubMed ID: 10861114
[TBL] [Abstract][Full Text] [Related]
18. Effect of 4% gelofusine plus antibiotics on renal impairment and mortality in high-risk cirrhotic patients with spontaneous bacterial peritonitis.
Sirinthornpunya S; Luangvichcharoen K
J Med Assoc Thai; 2013 Mar; 96 Suppl 3():S77-83. PubMed ID: 23682527
[TBL] [Abstract][Full Text] [Related]
19. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement.
Albillos A; de la Hera A; González M; Moya JL; Calleja JL; Monserrat J; Ruiz-del-Arbol L; Alvarez-Mon M
Hepatology; 2003 Jan; 37(1):208-17. PubMed ID: 12500206
[TBL] [Abstract][Full Text] [Related]
20. Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost.
Angeli P; Guarda S; Fasolato S; Miola E; Craighero R; Piccolo F; Antona C; Brollo L; Franchin M; Cillo U; Merkel C; Gatta A
Aliment Pharmacol Ther; 2006 Jan; 23(1):75-84. PubMed ID: 16393283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
